Global Women’s Health Diagnostics Market Size study & Forecast, by Type (Diagnostic Devices, Diagnostic Tests, Accessories and Consumables), By End User (Hospitals and Clinics, Diagnostic and Imaging Centers, Homecare, Others) and Regional Analysis, 2022-2029
Global Women’s Health Diagnostics Market is valued approximately USD 20.52 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 6.9 % over the forecast period 2022-2029. Women’s Health Diagnostics comprised of screening, testing, or diagnosing, and monitoring of several disorders affecting women such as ovarian cancer, cervical cancer, menopause, and pregnancy among others. There are various test kinds available to diagnose illnesses affecting women's health. Medical diagnostic tools including biopsy machines, imaging and monitoring systems, mammography machines, and others help with illness screening and diagnosis by detecting cancer, clearing obstructions, and taking pictures of inside organs. The diagnostic test comprises examinations for ovarian cancer, breast cancer, cervical cancer, prenatal genetic screening, and carrier detection. Moreover, the increasing incidence of cancers among women and growing demand for the point of care diagnostic testing are key factors driving the market growth.
Over the years the incidents of various cancers including breast and ovarian has significantly increased among female, hence creating strong demand for the Global Womens Health Diagnostics Market. For instance – as per the International Agency for Research on Cancer (IARC) – in 2020, in North America around 26600 cases of ovarian cancers were reported, and this number is further projected to reach to 30400 in 2030, and around 33500 in 2040. Additionally, in Europe around 66600 cases of ovarian cancer were reported in 2020, and this number is projected to reach to 70900 in 2030, and further 72900 in 2040. Also, growing awareness about women’s health-related tests as well as rising number of developments and strategic partnerships between leading market players would create lucrative growth prospectus for the market over the [projected period. However, high Cost associated with diagnostic imaging systems and procedures hinders the market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Women’s Health Diagnostics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of branded products and the increasing number of technological developments related to diagnosis of women and imaging techniques in the region would offer lucrative opportunity for the market during the projected period. Whereas Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, and rising demand for fertility testing monitors coupled with rapid acceptance of POC diagnostics and PST practices in the region would offer lucrative growth prospectus for the market over the projected period.
Major market player included in this report are:
Abbott Laboratories
Becton, Dickinson and Company
Cardinal Health, Inc.
F. Hoffmann-La Roche Ltd.
General Electric Company
Hologic, Inc.
Koninklijke Philips N.V.
Quest Diagnostics Incorporated
Siemens Medical Solutions USA, Inc.
bioMérieux SA.
Recent Developments in the Market:
In June 2022, Mylab Discovery Solutions announced launch of PregaScreen, an at-home pregnancy test kit. This marks the company's entry into the female healthcare market. PregaScreen, priced at USD 0.66, intended to confirmation of pregnancy.
In November 2022, An Israel-based start-up named Salignostics has invented a novel pregnancy test kit — SaliStick, that make use of the saliva to determine pregnancy. The kit has been launched in Israel and would be available in the global markets from 2023.
Global Womens Health Diagnostics Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Type, End User, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.
The detailed segments and sub-segment of the market are explained below:
By Type
Diagnostic Devices
Diagnostic Tests
Accessories and Consumables
By End User
Hospitals and Clinics
Diagnostic and Imaging Centers
Homecare
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
Companies Mentioned
Abbott Laboratories
Becton, Dickinson and Company
Cardinal Health, Inc.
F. Hoffmann-La Roche Ltd.
General Electric Company
Hologic, Inc.
Koninklijke Philips N.V.
Quest Diagnostics Incorporated
Siemens Medical Solutions USA, Inc.
bioMérieux SA.
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook